These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19801856)

  • 1. Anchoring of ulex europaeus agglutinin to chitosan nanoparticles-in-microparticles and their in vitro binding activity to bovine submaxillary gland mucin.
    Li FQ; Fei YB; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1045-9. PubMed ID: 19801856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wheat germ agglutinin anchored chitosan nanoparticles and its conjugation with N-acetylglucosamine].
    Li H; Bi J; Xu XM; Li FQ
    Yao Xue Xue Bao; 2012 Jan; 47(1):131-4. PubMed ID: 22493818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus.
    Ezpeleta I; Arangoa MA; Irache JM; Stainmesse S; Chabenat C; Popineau Y; Orecchioni AM
    Int J Pharm; 1999 Nov; 191(1):25-32. PubMed ID: 10556737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
    Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
    Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios.
    Hejjaji EMA; Smith AM; Morris GA
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1610-1617. PubMed ID: 30282010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding specificity of Anguilla anguilla agglutinin (AAA) in comparison to Ulex europaeus agglutinin I (UEA-I).
    Baldus SE; Thiele J; Park YO; Hanisch FG; Bara J; Fischer R
    Glycoconj J; 1996 Aug; 13(4):585-90. PubMed ID: 8872115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical cross-linking: A feasible approach to prolong doxylamine/pyridoxine release from spray-dried chitosan microspheres.
    Katsarov P; Pilicheva B; Uzunova Y; Gergov G; Kassarova M
    Eur J Pharm Sci; 2018 Oct; 123():387-394. PubMed ID: 30077710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization.
    Malik B; Goyal AK; Markandeywar TS; Rath G; Zakir F; Vyas SP
    J Drug Target; 2012 Jan; 20(1):76-84. PubMed ID: 21942475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering effect of N-acetylglucosamine on retarded drug release from a lectin-anchored chitosan nanoparticles-in-microparticles system.
    Li H; Dong WF; Zhou JY; Xu XM; Li FQ
    Int J Pharm; 2013 Jun; 449(1-2):37-43. PubMed ID: 23587965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery.
    Barbi Mda S; Carvalho FC; Kiill CP; Barud Hda S; Santagneli SH; Ribeiro SJ; Gremião MP
    J Nanosci Nanotechnol; 2015 Jan; 15(1):865-74. PubMed ID: 26328451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of microparticles with gelatin and chitosan.
    Prata AS; Grosso CR
    Carbohydr Polym; 2015 Feb; 116():292-9. PubMed ID: 25458303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
    Mishra D; Jain N; Rajoriya V; Jain AK
    J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel.
    Yonezawa S; Nakamura T; Tanaka S; Sato E
    J Natl Cancer Inst; 1982 Oct; 69(4):777-85. PubMed ID: 6181281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
    Barakat NS; Almurshedi AS
    J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles.
    Dmour I; Taha MO
    Int J Pharm; 2017 Aug; 529(1-2):15-31. PubMed ID: 28634140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
    Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
    Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoparticles: preparation, size evolution and stability.
    Rampino A; Borgogna M; Blasi P; Bellich B; Cesàro A
    Int J Pharm; 2013 Oct; 455(1-2):219-28. PubMed ID: 23886649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.